Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
330.91
+5.08 (1.56%)
At close: Nov 17, 2025, 4:00 PM EST
332.00
+1.09 (0.33%)
After-hours: Nov 17, 2025, 7:27 PM EST
Elevance Health Revenue
Elevance Health had revenue of $50.71B in the quarter ending September 30, 2025, with 12.33% growth. This brings the company's revenue in the last twelve months to $194.82B, up 11.96% year-over-year. In the year 2024, Elevance Health had annual revenue of $176.81B with 3.19% growth.
Revenue (ttm)
$194.82B
Revenue Growth
+11.96%
P/S Ratio
0.38
Revenue / Employee
$1,869,674
Employees
104,200
Market Cap
73.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 176.81B | 5.47B | 3.19% |
| Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
| Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
| Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
| Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ELV News
- 7 days ago - Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December - Benzinga
- 7 days ago - Elevance Health Foundation Invites Applications for $5 Million Patient Safety Prize Through New Community Action Leadership Initiative - Business Wire
- 8 days ago - First Eagle U.S. Fund Q3 2025 Portfolio Review - Seeking Alpha
- 13 days ago - Columbia Balanced Fund Q3 2025 Portfolio Update - Seeking Alpha
- 18 days ago - Artisan Global Value Fund Q3 2025 Portfolio Update - Seeking Alpha
- 24 days ago - Elevance Health: Q3 Figures Underscore Slow But Steady Recovery - Seeking Alpha
- 26 days ago - US health insurance premiums rose to $27,000 for families in 2025 - Reuters
- 26 days ago - HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members - Business Wire